P P Tak Selected Research

P P Tak Research Topics

Disease

81	Rheumatoid Arthritis 02/2018 - 02/2000
30	Inflammation (Inflammations) 01/2017 - 01/2000
28	Arthritis (Polyarthritis) 01/2017 - 01/2000
23	Necrosis 09/2012 - 04/2003
12	Experimental Arthritis 01/2017 - 01/2000
8	Osteoarthritis 03/2006 - 03/2000
6	Psoriatic Arthritis 01/2012 - 07/2004
5	Autoimmune Diseases (Autoimmune Disease) 04/2014 - 04/2006
3	Sjogren's Syndrome (Sjogren Syndrome) 04/2014 - 02/2006
3	Rheumatic Diseases (Rheumatism) 01/2012 - 07/2005
3	Fatigue 03/2010 - 06/2008
3	Reactive Arthritis (Reiter Disease) 03/2006 - 03/2004
3	Spondylarthropathies 05/2005 - 12/2002
3	Joint Diseases (Joint Disease) 04/2005 - 03/2000
2	Infections 02/2012 - 03/2007
2	Arthralgia (Joint Pain) 03/2010 - 09/2008
2	Atherosclerosis 09/2009 - 08/2009
2	Pain (Aches) 08/2008 - 06/2008
2	Multiple Sclerosis 10/2004 - 09/2004
1	Hypersensitivity (Allergy) 11/2015
1	Injection Site Reaction 11/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2012
1	Melanoma (Melanoma, Malignant) 06/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2009

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 01/2017 - 02/2000
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014 - 02/2000
14	AntibodiesIBA 03/2015 - 03/2004
10	Rituximab (Mabthera)FDA Link 11/2015 - 06/2008
9	Adalimumab (Humira)FDA Link 09/2012 - 03/2009
9	Methotrexate (Mexate)FDA LinkGeneric 02/2012 - 07/2000
8	ChemokinesIBA 09/2011 - 09/2001
8	Infliximab (Remicade)FDA Link 12/2010 - 07/2004
7	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2001
6	Biological ProductsIBA 01/2016 - 06/2006
6	Antirheumatic Agents (DMARD)IBA 08/2013 - 07/2000
6	Tumor Necrosis Factor InhibitorsIBA 02/2012 - 07/2007
5	Rheumatoid FactorIBA 03/2014 - 05/2005
5	Immunoglobulin M (IgM)IBA 03/2014 - 06/2009
5	Interferon-betaIBA 06/2007 - 02/2000
4	AutoantibodiesIBA 03/2014 - 09/2005
4	Leflunomide (Arava)FDA LinkGeneric 02/2012 - 07/2000
4	Matrix Metalloproteinases (MMPs)IBA 12/2011 - 09/2001
4	InterleukinsIBA 06/2009 - 07/2003
4	NF-kappa B (NF-kB)IBA 07/2007 - 08/2000
3	TACI receptor-IgG Fc fragment fusion proteinIBA 11/2015 - 01/2008
3	Peptides (Polypeptides)IBA 03/2015 - 01/2001
3	Peptidoglycan (Murein)IBA 01/2015 - 03/2000
3	Anti-Citrullinated Protein AntibodiesIBA 03/2014 - 09/2008
3	Chemokine ReceptorsIBA 09/2011 - 10/2004
3	Biomarkers (Surrogate Marker)IBA 08/2009 - 06/2005
3	Interleukin-6 (Interleukin 6)IBA 12/2006 - 02/2000
3	Granzymes (Granzyme)IBA 05/2005 - 01/2001
2	flt3 ligand protein (flt3 ligand)IBA 01/2015 - 02/2014
2	cyclic citrullinated peptideIBA 03/2014 - 09/2008
2	GlucocorticoidsIBA 09/2012 - 10/2006
2	Immunoglobulins (Immunoglobulin)IBA 05/2012 - 12/2010
2	EpitopesIBA 03/2010 - 09/2008
2	Interleukin-10 (Interleukin 10)IBA 08/2009 - 02/2006
2	LipidsIBA 08/2009 - 04/2006
2	Therapeutic UsesIBA 09/2008 - 09/2007
2	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2007 - 11/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2006 - 07/2005
2	InterferonsIBA 10/2006 - 03/2004
2	beta-Galactosidase (Lactaid)IBA 02/2006 - 04/2005
2	Monoclonal AntibodiesIBA 03/2005 - 02/2000
2	Tissue Inhibitor of Metalloproteinase-1IBA 07/2003 - 02/2000
2	Interleukin-1beta (Interleukin 1 beta)IBA 04/2003 - 02/2000
2	DNA (Deoxyribonucleic Acid)IBA 08/2001 - 03/2000
2	Metalloproteases (Metalloproteinases)IBA 08/2000 - 02/2000
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2017
1	GSK199IBA 01/2017
1	EnzymesIBA 01/2017
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 01/2017
1	Protein-Arginine DeiminasesIBA 01/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017
1	Protein-Arginine Deiminase Type 4IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 10/2015
1	CAM-3003IBA 10/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2015
1	Messenger RNA (mRNA)IBA 04/2014
1	B-Cell Activating FactorIBA 04/2014
1	Neutralizing AntibodiesIBA 04/2013
1	AdipokinesIBA 09/2012
1	ResistinIBA 09/2012
1	ASK8007 monoclonal antibodyIBA 02/2012
1	ocrelizumabIBA 02/2012
1	OsteopontinIBA 02/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2012
1	CX3C ChemokinesIBA 09/2011
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2010
1	TWEAK ReceptorIBA 01/2010
1	Immunomodulating AgentsIBA 09/2009
1	Macrophage Migration-Inhibitory FactorsIBA 08/2009
1	Etanercept (Enbrel)FDA Link 06/2009
1	N 30IBA 06/2009
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 06/2009

Therapy/Procedure

19	Therapeutics 10/2015 - 01/2000
3	Vagus Nerve Stimulation 02/2018 - 08/2014
2	Biological Therapy 01/2016 - 07/2007
1	Vagotomy 08/2014